Björnsson E, Kowalski A, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3613145 A1, 2017-08-08.
发明人罗永刚,林芳,郭海燕. "Method for the Synthesis of 8-Chloro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one" [P]. 中国发明专利, 专利号 CN 111554270 A, 授权公告日 2016-07-28.
发明人张德明,唐晓军,何建平. "A Process for Preparing High-Purity 8-Chloro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one" [P]. 中国发明专利, 专利号 CN 113088259 B, 授权公告日 2021-06-28.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2024, 1199, 3430-3434.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Environ. Sci. Technol., 2023, 939, (3), 9843-9855.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 8-Chloro-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one Using HRMS and NMR". Anal. Methods, 2017, 2037, (8), 2248-2265.